Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hoffmann

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
The Lancet. Oncology|January 30, 2008
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)Michael Pfreundschuh, Joerg Schubert, Marita Ziepert, et al.
Medicine|August 18, 2017
Causes of hematochezia and hemorrhagic antibiotic-associated colitis in children and adolescentsLaura Stampfer, Andrea Deutschmann, Elisabeth Dür, et al.
Cancer Cell|December 6, 2016
Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic LeukemiaSarah Ebinger, Erbey Ziya Özdemir, Christoph Ziegenhain, et al.
Leukemia|July 21, 2020
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of ageElias K Mai, Kaya Miah, Uta Bertsch, et al.
Scientific Reports|October 10, 2025
Automated radiomics model for prediction of therapy response and minimal residual disease from baseline MRI in multiple myelomaFabian Bauer, Marina Hajiyianni, Niels Weinhold, et al.
Leukemia|November 17, 2021
Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of ageElias K Mai, Kaya Miah, Uta Bertsch, et al.
Nature|December 16, 2016
Early dissemination seeds metastasis in breast cancerHedayatollah Hosseini, Milan M S Obradović, Martin Hoffmann, et al.
Frontiers in Digital Health|July 2, 2026
Selecting medical research data platforms for translational biomedical research: a five-tier overview and requirement-weighted assessment frameworkMarc Jacobs, Samad Goudarzi, Jan Stücke, et al.
Leukemia|February 9, 2020
Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trialHartmut Goldschmidt, Elias K Mai, Jan Dürig, et al.
Molecular Oncology|October 5, 2024
Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patientsNataša Stojanović Gužvić, Florian Lüke, Steffi Treitschke, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
The Lancet. Oncology|January 30, 2008
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)Michael Pfreundschuh, Joerg Schubert, Marita Ziepert, et al.
Medicine|August 18, 2017
Causes of hematochezia and hemorrhagic antibiotic-associated colitis in children and adolescentsLaura Stampfer, Andrea Deutschmann, Elisabeth Dür, et al.
Cancer Cell|December 6, 2016
Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic LeukemiaSarah Ebinger, Erbey Ziya Özdemir, Christoph Ziegenhain, et al.
Leukemia|July 21, 2020
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of ageElias K Mai, Kaya Miah, Uta Bertsch, et al.
Scientific Reports|October 10, 2025
Automated radiomics model for prediction of therapy response and minimal residual disease from baseline MRI in multiple myelomaFabian Bauer, Marina Hajiyianni, Niels Weinhold, et al.
Leukemia|November 17, 2021
Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of ageElias K Mai, Kaya Miah, Uta Bertsch, et al.
Nature|December 16, 2016
Early dissemination seeds metastasis in breast cancerHedayatollah Hosseini, Milan M S Obradović, Martin Hoffmann, et al.
Frontiers in Digital Health|July 2, 2026
Selecting medical research data platforms for translational biomedical research: a five-tier overview and requirement-weighted assessment frameworkMarc Jacobs, Samad Goudarzi, Jan Stücke, et al.
Leukemia|February 9, 2020
Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trialHartmut Goldschmidt, Elias K Mai, Jan Dürig, et al.
Molecular Oncology|October 5, 2024
Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patientsNataša Stojanović Gužvić, Florian Lüke, Steffi Treitschke, et al.
Pageof 18